Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Quinoxaline compounds as type III receptor tyrosine kinase inhibitors

Quinoxaline compounds as type III receptor tyrosine kinase inhibitors

US Patent 10689362 · Granted Jun 23, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Cut metal gate process for reducing transistor spacing2025
Anti-CD73 antibodies and use thereof2025
SRAM structure and method for forming the same2024
Anti-human CSF-1R antibody and uses thereof2024
Anti-human CSF-1R antibody and uses thereof2024
Touch sensing apparatus with noise reduction and electronic device including the2024
AFE circuit and related gain amplifier2024
Etch stop layer between substrate and isolation structure2024
Anti-PD-L1 antibodies and anti-PD-L1/IL10 fusion proteins2023
Display-and-touch system having interference sensing capacitor2023
Cut metal gate process for reducing transistor spacing2023
Touch sensing method with noise reduction2023